Products found to contain undeclared medicines
|
| |
| Canada: Unauthorized health products from Kausch International Goods may pose serious health risks |
| |
Health Canada is warning consumers about unauthorized health products that it removed from sale from Kausch International Goods’ online store and its associated warehouse in Calgary, AB. The unauthorized products were labelled or previously tested and found to contain prescription drugs and may pose serious health risks. The affected products are:
- Brilliant Skin Essentials Topical Solution (Toner) (Skin lightening): Labelled to contain hydroquinone and tretinoin
- Brilliant Skin Essentials Brilliant Rejuv Set (Skin lightening): Labelled to contain hydroquinone and tretinoin
- Brilliant Skin Essentials Brilliant Rejuv Topical Cream (Skin lightening): Labelled to contain hydroquinone and tretinoin
- Brilliant Skin Essentials Rejuvenating Facial Toner (Skin lightening): Product with similar packaging (previously removed from sale) was tested and found to contain tretinoin
- Solmux carbocisteine 100mg/5ml Pediatric Syrup (Mucolytic): Labelled to contain carbocisteine
- Solmux carbocisteine 200mg/5ml Pediatric Syrup (Mucolytic): Labelled to contain carbocisteine
- Solmux carbocisteine Forte 500mg/5ml Adult Suspension (Mucolytic): Labelled to contain carbocisteine
Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. For example, they could contain high-risk ingredients, such as prescription drugs, additives or contaminants that may or may not be listed on the label. These ingredients could interact with other medications and foods. In addition, these products may not actually contain the active ingredients that consumers would expect them to contain to help maintain and improve their health.
Prescription drugs should only be used under the advice and supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/unauthorized-health-products-kausch-international-goods-may-pose-serious-health-risks
In Hong Kong, Solmux Pediatric Susp 200mg/5ml (HK-34628) is a pharmaceutical product registered by Unam Corporation Ltd. The packaging of Solmux carbocisteine 200mg/5ml Pediatric Syrup above-mentioned in the Health Canada’s announcement is different from the registered packaging of the product in Hong Kong.
The other products above-mentioned in the Health Canada’s announcement are not registered pharmaceutical products in Hong Kong.
Ends/Thursday, Mar 2, 2023
Issued at HKT 14:30
|
| |
